These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35175155)

  • 1. Real-life experiences with goal-directed prohemostatic therapy with fibrinogen concentrate, prothrombin complex concentrate, and recombinant factor VIIa: a retrospective study of 287 consecutive patients.
    Vigstedt M; Henriksen HH; Chaachouh HW; Stensballe J; Johansson PI
    Scand J Clin Lab Invest; 2022 Apr; 82(2):156-161. PubMed ID: 35175155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.
    Schöchl H; Nienaber U; Hofer G; Voelckel W; Jambor C; Scharbert G; Kozek-Langenecker S; Solomon C
    Crit Care; 2010; 14(2):R55. PubMed ID: 20374650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients.
    Schöchl H; Voelckel W; Maegele M; Kirchmair L; Schlimp CJ
    Crit Care; 2014 Jul; 18(4):R147. PubMed ID: 25008277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
    Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
    Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
    Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate.
    Schöchl H; Forster L; Woidke R; Solomon C; Voelckel W
    Anaesthesia; 2010 Feb; 65(2):199-203. PubMed ID: 19995349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
    Zentai C; van der Meijden PE; Braunschweig T; Hueck N; Honickel M; Spronk HM; Rossaint R; Grottke O
    Anesth Analg; 2016 Jul; 123(1):38-48. PubMed ID: 27192476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of fibrinogen concentrate combined with prothrombin complex maintains hemostasis in children undergoing congenital heart repair (a long-term propensity score-matched study).
    Velik-Salchner C; Tauber H; Rastner V; Pajk W; Mittermayr M; Wally D; Kilo J; Vondrys D; Fries D; Fritz J; Streif W
    Acta Anaesthesiol Scand; 2021 Oct; 65(9):1178-1186. PubMed ID: 34152599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study.
    Schlimp CJ; Voelckel W; Inaba K; Maegele M; Schöchl H
    Scand J Trauma Resusc Emerg Med; 2013 Oct; 21():74. PubMed ID: 24103457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin complex concentrate for critical bleeding.
    Patanwala AE; Acquisto NM; Erstad BL
    Ann Pharmacother; 2011 Jul; 45(7-8):990-9. PubMed ID: 21730276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
    Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.
    Chow JH; Lee K; Abuelkasem E; Udekwu OR; Tanaka KA
    Semin Cardiothorac Vasc Anesth; 2018 Jun; 22(2):164-173. PubMed ID: 29099345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury.
    Joseph B; Hadjizacharia P; Aziz H; Kulvatunyou N; Tang A; Pandit V; Wynne J; O'Keeffe T; Friese RS; Rhee P
    J Trauma Acute Care Surg; 2013 Jan; 74(1):248-53. PubMed ID: 23271101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.
    Ekelund K; Hanke G; Stensballe J; Wikkelsøe A; Albrechtsen CK; Afshari A
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):680-692. PubMed ID: 25660118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
    DeLoughery E; Avery B; DeLoughery TG
    Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.